Stopping Wegovy: what happens when you stop taking it

What the trial data actually shows when people stop semaglutide

The STEP 1 extension study is the clearest window we have. After 68 weeks on semaglutide 2.4mg, participants had lost an average of around 15% of body weight. A subset then stopped treatment and were followed for a further 52 weeks. By the end of that year, about two-thirds of the weight lost had returned. Appetite, hunger signalling and metabolic rate (all of which semaglutide modifies while you are taking it) reverted towards pre-treatment levels once the medicine cleared the body.

This isn't a failure of willpower. Semaglutide works by activating GLP-1 receptors that influence satiety, slow gastric emptying and reduce appetite. Remove the medicine and those receptors are no longer being stimulated in the same way. The biology reasserts itself. NHS guidance on semaglutide makes this point plainly: Wegovy manages weight, it doesn't permanently reset the system that regulates it.

The rate of regain isn't uniform. Some people regain weight quickly; others more slowly. Factors include how much lifestyle change has been embedded, whether comorbidities are affecting metabolism, and individual variation in how strongly appetite returns. What the data doesn't support is the idea that a year or two of treatment permanently resolves the problem for most people, and our page on whether you can stop taking semaglutide explores this evidence in more detail.

Why stopping abruptly is harder than it sounds

Semaglutide has a half-life of roughly seven days, meaning it clears the body gradually over several weeks after the last injection. During that window, appetite typically begins to climb before the medicine has fully gone. Some people find the transition manageable; others describe a sharp return of hunger that catches them off guard.

There's no formally licensed tapering protocol for Wegovy in the same way there is for, say, corticosteroids. That said, many prescribers prefer to step down the dose before stopping entirely rather than jumping straight from 2.4mg to nothing, because the adjustment is gentler. If you are wondering how to stop taking Wegovy safely, the short answer is: not without a conversation with your prescriber first.

Practical matters also come into play. If you keep your pen in the fridge door between weekly doses and one week simply forget to collect a repeat, that unplanned pause is different from a deliberate, supervised wind-down. Unplanned gaps can increase the chance of side effects returning when you restart, and restarting at a higher dose than your body has adjusted to is something a prescriber needs to guide.

When stopping might actually be the right decision

There are legitimate reasons to stop. A serious side effect, a planned pregnancy (Wegovy is not recommended during pregnancy or while trying to conceive), a surgical procedure where the anaesthetist needs to know you are on a GLP-1 medicine, or simply reaching a weight and health goal that both you and your prescriber feel is stable enough to trial life without the medicine. None of these make stopping wrong, they make it a clinical decision rather than a spontaneous one.

NICE's recommendation for Wegovy on the NHS under TA875 includes a maximum two-year treatment duration within specialist services, with a review if less than 5% weight loss is achieved in the first six months. Private prescribers are not bound by that two-year cap, but they do reassess at each repeat. If the medicine is not working as expected or side effects are ongoing, that review matters.

For people asking whether it's sensible to stop after reaching a weight-loss goal, the honest clinical answer is: it depends on your individual health picture. Some people sustain a good proportion of their loss; many don't without continued support. The question of when the timing is right is one your prescriber should help you answer, not a decision to make alone based on how the scales look one morning.

Thinking about Wegovy as a long-term medicine, not a short course

The framing that tends to help most is this: Wegovy is closer to a long-term maintenance medicine than a short course of antibiotics. You wouldn't stop a blood-pressure tablet because your blood pressure had normalised, without asking your GP first. The same logic applies here, and our guide on what happens when you stop taking Wegovy covers what to expect in practical terms. NHS England's guidance on weight-management injections reinforces this, describing these medicines as part of a sustained approach to weight management rather than a standalone fix.

That doesn't mean everyone takes Wegovy indefinitely. It means the exit strategy deserves the same clinical thought as the starting decision. If cost is part of the calculation, it's worth understanding how Wegovy pricing compares across UK providers before deciding that stopping is the only option. If you are already on treatment and want to discuss whether your current dose or plan still makes sense, checking your eligibility with our prescribers is a no-pressure starting point, one conversation, no subscription, no obligation.